|
|
A cohort study among workers exposed to benzene in China
|
Z01 CP010120-02060
|
$1,557,754
|
$311,551
|
Hayes, Richard
|
DCEG (NCI)
|
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
5R01CA121180-03
|
$267,494
|
$267,494
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
|
|
A Genome-Wide Association Study of Non-Hodgkin Lymphoma
|
5R01CA122663-03
|
$529,626
|
$529,626
|
Skibola, Christine
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
Z01 BC 011064
|
$228,515
|
$228,515
|
Mock, Beverly
|
CCR (NCI)
|
|
|
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
|
5R01CA107300-05
|
$270,281
|
$135,141
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Pull-Push Strategy for Lymphoma Immunotherapy
|
5K08CA105064-05
|
$128,547
|
$128,547
|
Song, Wenru
|
BAYLOR RESEARCH INSTITUTE
|
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
Z01 SC 010356
|
$365,279
|
$182,640
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
$3,138
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
$7,500
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
$219,799
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Activation of BCL-2 in Hematologic Malignancies
|
2R01CA056764-14A1
|
$290,500
|
$290,500
|
BOXER, LINDA
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$258,071
|
$38,711
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Activation of the LMP-1 Protein of Epstein-Barr Virus
|
3R01CA095043-05S1
|
$46,501
|
$23,251
|
MARTIN, JENNIFER
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
|
Activation of the LMP-1 Protein of Epstein-Barr Virus
|
5R01CA095043-05
|
$231,698
|
$115,849
|
MARTIN, JENNIFER
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
2U01CA096230-06
|
$718,223
|
$165,191
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-25
|
$432,500
|
$432,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
AIDS cancer match, non-U.S.
|
Z01 CP010176-10084
|
$188,362
|
$18,836
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S1
|
$249,599
|
$57,408
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S2
|
|
$0
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S3
|
$250,067
|
$57,515
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Corsortium
|
5U01CA121947-03
|
$3,732,363
|
$858,443
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
|
5R01CA122658-02
|
$561,207
|
$140,302
|
KNOBF, M
|
YALE UNIVERSITY
|
|
|
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression
|
1R01CA130752-01A1
|
$309,175
|
$309,175
|
FLEMINGTON, ERIK
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Analysis of the p53 in vivo using a unique mouse model
|
2R01CA100193-06
|
$335,365
|
$33,537
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,300,000
|
$260,000
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Animal Model and Genotyping Core Support Facility
|
Z01 BC 011047
|
$1,033,915
|
$206,783
|
DuBois, Wendy
|
CCR (NCI)
|
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-03
|
$5,000
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Antiangiogenic Therapy for AIDS-Associated Lymphomas
|
5R21CA119918-02
|
$157,000
|
$157,000
|
ROCHFORD, ROSEMARY
|
UPSTATE MEDICAL UNIVERSITY
|
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
Z01 BC 010647
|
$410,318
|
$205,159
|
Rader, Christoph
|
CCR (NCI)
|
|
|
Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy
|
5K23CA123149-02
|
$136,080
|
$136,080
|
Neelapu, Sattva
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$39,637
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$1,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Aspartame Intake and the Risk of Cancer
|
5R03CA130054-02
|
$116,957
|
$38,596
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
ATBC Study
|
Z01 CP010195-03031
|
$759,338
|
$15,187
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
2U10CA045450-22
|
$761,812
|
$15,236
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
B Cell Lymphoma Therapy
|
5R01CA121039-02
|
$244,245
|
$244,245
|
CHOI, YONG
|
OCHSNER CLINIC FOUNDATION
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$19,248
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$8,210
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$106,050
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-07
|
$1,049,588
|
$41,984
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-14
|
$139,719
|
$27,944
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
Z01 BC 010030
|
$863,565
|
$69,085
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
|
2R01CA092104-05A2
|
$258,741
|
$258,741
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Biomarkers of benzene exposure
|
Z01 CP010121-02035
|
$895,180
|
$304,361
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
|
BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma
|
5R21CA121569-02
|
$281,200
|
$281,200
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-20
|
$3,446,067
|
$1,895,336
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
$1,018,704
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Breast implant follow-up study
|
Z01 CP010128-01220
|
$31,576
|
$1,579
|
Brinton, Louise
|
DCEG (NCI)
|
|
|
c-Myc Expression during Lymphomagenesis
|
5R01CA068328-12
|
$337,199
|
$168,600
|
RUDDELL, M
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
c-Myc-regulated microRNAs in normal and pathologic cellular physiology
|
5R01CA120185-02
|
$309,168
|
$204,051
|
MENDELL, JOSHUA
|
JOHNS HOPKINS UNIVERSITY
|
|
Total relevant funding to Lymphoma for this search: $140,937,531
|
